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The use of ions in radiation therapy aims at improving the selectivity of the irradiation thanks to a
favourable depth-dose profile and, in case of heavy ions, to their enhanced radiobiological effect.
The treatment modality employing actively scanned pencil beams provides highly conformal dose
distributions but is sensitive to uncertainties in the dose calculation, delivery and measurement.
During the treatment, the delivery of the beam has to be controlled in real time and monitored with
high accuracy, including any effect due to patient positioning and motion. Based on the experience
gained in the collaboration with the CNAO (Centro Nazionale di Adroterapia Oncologica, Pavia,
Italy), this paper is intended to give an overview of recent techniques and trends for the delivery,
measurement and verification of the dose distribution in charged particle therapy with scanned
ion beams, focusing in particular on real time and online techniques.
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1. Introduction
What follows is a brief overview of the recent techniques and trends for the delivery, measure-
ment and verification of the dose distribution in charged particle therapy with scanned ion beams.
This will be partially focused on the CNAO facility (Centro Nazionale di Adroterapia Oncologica,
Pavia, Italy), due to the close collaboration with the INFN (Istituto Nazionale di Fisica Nucleare),
and particular emphasis will be given to real-time and on-line techniques, which are sometimes
considered at the cutting edge of the actual research.
1.1 Rational for particle therapy
Nowadays, radiation therapy is one of the most successfully applied cancer therapy, second
only to surgery, and, in the last few decades, there has been a growing interest toward the use
of charged particles [1]. There are basically three main reasons that make particle therapy so
appealing [2]. The first one is the favourable dose profile, that is the energy deposited by the
radiation as a function of the depth in the patient body, which is characterized by an initial plateau
followed by a steep peak (the Bragg peak) in the distal region. This allow to be more conformal
in the dose distribution with respect to photon irradiation, especially when treating deep located
tumours, lowering the dose to the healthy tissues. The second reason is a better beam collimation
inside the target: in fact, the ion beam is mainly broadened by the multiple scattering, which effect
is much lower than the one of the Compton effect on a photon beam. The third reason is the
higher biological effectiveness of the charged particle, which result more efficient in cell killing
with respect to photons. This means that the same level of cell survival is achievable delivering a
lower dose to the target.
1.2 Accelerators
Currently there are two kinds of accelerators used in the clinical facilities: synchrotrons and
cyclotrons (or synchro-cyclotron). These are far more smaller than the ones used in high energy
physics, since the energy are lower, and the more compact the more appealing they are for the hos-
pitals which often have a limited space to install them. The typical diameter of a clinical cyclotron
[1] is about 4 to 5 meters and they are currently used only for protons, with maximum energies
ranging from 60 to 250 MeV, while the diameter of a clinical synchrotron ranges from 8–10 meters
for protons, up to 40 meters for carbon ions, with a maximum energy ranging between 220 to 250
MeV for protons and from 320 to 800 MeV/u in the case of carbon ions. To reduce the machine
diameter, in the last years there is a growing interest toward superconducting cyclotrons to be used
also for carbon ions [3].
1.3 Delivery systems
There are two techniques to deliver the beam, namely passive scattering and active scanning
[4]. In passive scattering, the proton beam is spread by placing scattering material in its path. A
single scatterer broadens the beam sufficiently for the coverage of small fields, while, in the case of
larger fields, a second scatterer is needed to ensure a uniform dose profile; then a combination of
custom collimators and compensators conforms the dose to the target volume. The active scanning,
1
P
o
S(INPC2016)123
Control of the dose distribution in charged particle therapy Lorenzo Manganaro
instead, exploits the ion charge to deflect a narrow “pencil” beam through a couple of bending mag-
nets. Hence the target is divided in monoenergetic layers, and for each of them the dose is delivered
in a grid of spot, where the number of particle for each spot is defined by the treatment planning
system (TPS). This is the best and most advanced technique since it offers a better conformity to
the target [5], avoiding at the same time the need of field-specific hardware (i.e. collimators and
compensators) which are responsible for a higher neutron contamination [6]. Nevertheless, besides
its proved benefits [7], the so called intensity modulated particle therapy (IMPT), achieved with the
active scanning, has also some drawbacks. In particular it is more sensible to patient positioning
or moving [8, 9], range uncertainties [10, 11] and dose calculation [12]. Therefore, to preserve its
high precision and ensure the stability and reproducibility of the treatment, pencil beam scanning
(PBS) requires very accurate control and monitoring systems.
1.4 The CNAO facility
The CNAO medical center is a hospital-based particle therapy facility equipped with a custom
synchrotron and dose delivery system (DDS) to provide actively scanned proton and carbon ion
beams. The energy ranges from 62 to 228 MeV for protons and from 115 to 400 MeV/u for
carbon ions, which correspond to a range in water of 3–32 cm and 3–27 cm respectively. The
maximum beam flux is 1010 protons per second and 108 carbon ions per second, with a full width
half maximum (FWHM) at the isocenter of 8–10 mm and 4–6 mm for protons and carbon ions
respectively. Three treatment rooms are available, two of which are equipped with a horizontal
fixed beam line and the third one has both an horizontal and a vertical fixed lines [13].
The patient treatment control flow starts from the TPS which creates a plan defining the spots,
the energies and the number of particles per spot to be delivered. The plan is then extended and
sent to the treatment console which dialogues with the synchrotron to set the energy layer by layer
and to stop the irradiation when a layer is completed. During the delivery, the beam is extracted
and steered by the scanning magnets (section 1.3). Between the magnets and the patient, the beam
crosses the monitor chambers that monitor the number of particles and the beam position: if the
detected position of the beam is wrong (out of 1 mm from the planned position) a warning signal is
sent to the control system that applies an offset to the scanning magnets in order to correct on-line
the beam position.
2. Detectors for beam control
2.1 Ionization chambers
The mainstream detectors used as beam monitors are the ionization chambers (IC). As an ex-
emplary case, at CNAO the monitor chambers are enclosed in two independent steel boxes [14].
The first one contains an integral chamber, intended to measure the beam flux, and two strip cham-
bers (128 strips, 1.65 mm wide) to measure the beam position or, better, the projection of the beam
on the x and y axis respectively. The size of these detectors is 24×24 cm2, to cover the maximum
beam size. The detector front-end readout is based on custom designed boards, which host appli-
cation specific integrated circuit (ASIC) electronics custom designed for this purpose [15, 16]. The
readout frequency for the integral chamber is about 1 MHz, while for the strip chambers 20 and 10
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kHz respectively for x and y strips. The second box is redundant, but required for the certification
of the beam, and it is made of a back-up integral chamber and a pixel chamber (32×32 pixels, 6.6
mm wide) which can reconstruct the shape of the beam, which is lost by the strip chambers.
In the case of very high-intensity beams, such as the laser-driven ion beams [17], it may be nec-
essary to correct for the recombination effect observed inside the IC. This could be done exploiting
a multi-gap chamber [18, 19, 20] this device includes two or three parallel plate ionization cham-
bers with independent anodes and cathodes separated by gaps of different thickness in order to have
different charge recombination effects and therefore different charge collection efficiencies. The
charge produced in the gas is proportional to the gap width. However, the charge collected by each
chamber is expected to deviate from the gap width proportionality because of the inefficiencies due
to charge recombination existing with high intensity beams. The deviation from proportionality
can be used to determine the collection efficiency and to correct for it.
2.2 Ultra fast silicon detectors
At the moment, through the monitors chambers described above (section 2.1) it is possible to
measure both the beam flux and position. Recently the INFN-Torino is working on a new kind of
detectors to be put on the beam line which would be able to count directly the number of particles
in the beam. If this would be possible, then this information could be used in combination with the
IC measurements to get a direct measurement of the ion stopping power, hence to verify the ion
energy. The challenging topic is that to have a maximum uncertainty on the particle range of 1 mm,
which is the upper limit for the clinical practice, the number of particles should be measured with
an accuracy of about 0.1%. Therefore, considering the high value of beam flux, very fast (i.e. thin)
and segmented detectors (to avoid the pile-up effect) are required. To address this issue, we are
investigating the possibility of using the so called ultra-fast silicon detectors (UFSD) [21], which
exploit the same design of the low gain avalanche detectors for the charge multiplication: a gain of
a factor 10 in the signal amplitude is obtained by adding to the silicon detector a layer with a really
high doping concentration to reach an electric field of about 300 kV/cm, which is enough to have
a good signal and not so much to have problems with the dead time. The time resolution obtained
is about 20 ps. Currently, one of the biggest issue is the radiation resistance, because if the doping
concentration is altered the gain results rapidly decreasing [22].
2.3 Gas electron multiplier
Recently, there is a new interest in the application of gas electron multiplier (GEM)-based
detectors as beam monitor for the daily quality assurance at CNAO. Very preliminary results have
been actually published about this topic [23] but they seems to be very promising, and the possibil-
ity to use them as substitutes of the strip chambers has to be investigated.
3. Online imaging and range verification
As mentioned in section 1.3, one of the main issues in IMPT is the range uncertainty, since
the more conformal is the dose distribution the more sensible is the outcome to deviations from
the prescriptions. Imaging techniques play a fundamental role in facing this problem. Moreover,
on-line imaging could really improve the control and quality of the particle therapy treatment.
3
P
o
S(INPC2016)123
Control of the dose distribution in charged particle therapy Lorenzo Manganaro
Here I will briefly mention three of the main and most promising imaging techniques, for the
characterization of the Bragg peak and control of the dose distribution (a detailed review of this
technique is beyond the scope of this paper: for a detailed description see for example [24]).
3.1 Prompt-gamma imaging
The prompt-gamma imaging is based on the idea to reconstruct the position of the Bragg peak
exploiting the photons emitted in the wake of the inelastic interaction between the particles of
the beam and the nuclei of the target. Currently, there are several methods under development to
exploit the prompt-gamma emission [24], but the slit camera [25, 26] is the only system which has
been successfully applied in a real patient treatment [27]. This is basically a knife-edge shaped slit
collimator which projects the prompt-gamma ray emission profile onto an array of 40 individual
scintillation detectors, arranged in two rows and optimized for detecting gamma rays of 3–6 MeV
energy, resulting in a spatially resolved gamma profile.
3.2 Ionoacustic characterization of the Bragg peak
One of the emerging imaging techniques which aims at reconstructing the deposited dose
profile inside the target is the ionoacustic tomography (IAT) [28] which exploits the so called
ionoacoustic effect: when the particle beam crosses the target, a great amount of energy is deposited
in correspondence of the location of the Bragg peak. This energy deposition induce a local heating
and consequently a fast thermal expansion which generates a pressure wave. Hence, by detecting
and mathematically inverting the ultrasound waves, it is possible to reconstruct the deposited dose
profile. Recently, it has been published an in-vivo proof of this technique [29], used in combination
with traditional ultra sound and optoacoustic clinical imaging to reach a submillimiter precision in
the localization of the Bragg peak.
3.3 In-beam PET
When traversing the tissues, a small fraction of ions create β+ emitting isotopes (e.g. 11C, 13N
and 15O) through nuclear interactions. The recombination of the emitted positrons with an electron
of the surrounding tissue, results in two coincident gammas that can be observed with a positron
emission tomography (PET) camera. Details of this technique can be found in references [24, 30],
but it is worth to mention that in-vivo PET range verification has, in some institutes, moved from
a research tool to clinical implementation, such as the case of the OpenPET scanner [31] tested at
HIMAC or the INFN-INSIDE project [32] which has been recently tested at CNAO. These systems
represent a powerful tool toward a possible image guided particle therapy, which would strongly
improve the quality of a particle therapy treatment.
4. The RIDOS system
To address the issue of real-time control of the dose delivered to the patient, a new system,
named RIDOS (Real-time Ion DOse planning and delivery System), has been developed by the
INFN-Torino group. The goal of RIDOS is to calculate on-line the delivered dose distribution,
using the measured data of the beams from the DDS and of the patient’s movement, and to compare
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it with the planned dose in order to be able, in principle, to correct on-line the treatment in case
of deviation from the original plan. This system runs on a dedicated Workstation with a NVIDIA-
TeslaK40c and it has been fully integrated in the CNAO DDS. It exploits the duty cycle of the
CNAO synchrotron, which has a spill of 1 second and a dead time of 3–4 seconds during which
RIDOS is able to evaluate a fast forward planning and a fast gamma index [33] to compare the
actual delivered dose with the original planning. This is made by a deep exploitation of the graphic
processing unit (GPU) calculation, which allows, in our case, to gain a factor 800 with respect to
the existing single core CPU calculation [34]. Moreover, RIDOS is also able to manage the patient
4D-CT together with the information of the real-time respiratory phase, in order to account for
intra-fraction target deformation.
5. Conclusion
This paper aimed at giving a brief overview of the main trends for the dose delivery and mon-
itoring in charged particle therapy, with a particular focus on the real-time and on-line techniques
which highlight the increasing demands on the accuracy of dose calculations, delivery and mea-
surement. A lot of work is still to be done to achieve a full clinical exploitation of the promising
features offered by scanned ion beams.
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